RECRUITINGINTERVENTIONAL
FearLess in NeuroOncology
FearLess in Neuro-Oncology
About This Trial
The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
Who May Be Eligible (Plain English)
Who May Qualify:
Patients:
- Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
- \>2 weeks post-cranial resection or biopsy
- Elevated Fear of Recurrence Distress Rating
- Primarily English speaking
- \>/= 18 years of age at the time of enrollment
Caregivers:
- nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)
- Elevated Fear of Recurrence Distress Rating
- Primarily English speaking
- \>/= 18 years of age at the time of enrollment
Who Should NOT Join This Trial:
Patient / Caregiver Exclusion:
- Cognitive impairment that might prohibit active intervention engagement
- Inability to understand and provide willing to sign a consent form
- Inability to attend virtual sessions due to unstable or no internet connection
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Patients:
* Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
* \>2 weeks post-cranial resection or biopsy
* Elevated Fear of Recurrence Distress Rating
* Primarily English speaking
* \>/= 18 years of age at the time of enrollment
Caregivers:
* nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)
* Elevated Fear of Recurrence Distress Rating
* Primarily English speaking
* \>/= 18 years of age at the time of enrollment
Exclusion Criteria:
Patient / Caregiver Exclusion:
* Cognitive impairment that might prohibit active intervention engagement
* Inability to understand and provide informed consent
* Inability to attend virtual sessions due to unstable or no internet connection
Treatments Being Tested
BEHAVIORAL
Fearless in Neuro-Oncology
FearLess is a newly developed, empirically-rooted, manualized psychological intervention consisting of an intake + 8 sessions delivered over a 12-week time period. It consists of weekly individual 60- to 90-minute virtual therapy sessions.
Locations (1)
Virginia Commonwealth University
Richmond, Virginia, United States